2 December, 2022 - Paris, France
The 5th edition of the Hybrid AF Therapies Summit is heading to Paris in 2022! Join your colleagues on 2nd December for a program covering AF treatment with Hybrid AF Therapies.
The program will explore how Hybrid AF Therapies are shaping new standards of care in atrial fibrillation advanced treatment.
Led by an international panel of speakers, the event will include sessions and roundtables on latest clinical trial results, best practices, patient selection criteria and procedural considerations.
Audience
Electrophysiologists and Cardiac Surgeons who are interested in developing a Hybrid AF program, or have already started it and would like to further advance their expertise through discussions with peers.
Level
All levels
Faculty
International Faculty
Agenda
The program commences on 2nd December from 09:00 until 17:00 CET
Topics include:
– Pathophysiology and treatment options for persistent and long-standing persistent AF
– Principles and techniques for epicardial ablation and LAA exclusion
– Review of the latest clinical data
– Expert panel discussions
– Opportunities and challenges of developing a Hybrid AF program
– Real-world case debate
Venue
Venue: Institut Mutualiste Montsouris
42 Bd Jourdan
75014
Paris, France
Accommodation
Hotel bookings will be allocated on an individual basis and you will receive a reservation confirmation by email. Please check your travel details tab in your AF Connect dashboard for your details.
The “Save the Date” flyer is available for download.
8:30 am - 8:45 am
Summit opening
8:45 am - 9:00 am
Welcome to Montsouris
- Konstantinos Zannis, MD & Frédéric Sebag, MD - Institut Mutualiste Montsouris, Paris, France
9:00 am - 11:00 am
Hybrid AF Therapies for persistent AF
- Frédéric Sebag, MD - Institut Mutualiste Montsouris, Paris, France
- Konstantinos Zannis, MD - Institut Mutualiste Montsouris, Paris, France
Past, present and future of AF treatment
- Gian Battista Chierchia, MD - Universitair Ziekenhuis Brussel, Brussels, Belgium
Seizing persistent AF: from 3D Mapping to 3D Thinking
- Nitesh Sood, MD - Southcoast Health, Fall River, MA, USA
Latest evidence on hybrid AF ablation for persistent AF
- Riyaz Kaba, MD - St George's Hospital, London, UK
Surgical epicardial ablation: workflow and procedural aspects
- Thorsten Hanke, MD - Asklepios Klinikum Harburg, Hamburg, Germany
Panel discussion: who can benefit the most?
11:00 am - 11:30 am
Coffee break
11:30 am - 1:00 pm
Case base panel discussion: best practices
- Thorsten Hanke, MD - Asklepios Klinikum Harburg, Hamburg, Germany
- Claudio Tondo, MD - Centro Cardiologico Monzino, Milano, Italy
Use of 3D mapping techniques in epicardial ablation
- Claudio Tondo, MD - Centro Cardiologico Monzino, Milano, Italy
Hybrid procedure at the time of Pulsed Field Ablation
- Nitesh Sood, MD - Southcoast Health, Fall River, MA, USA
Risk mitigation strategies
- Pragnesh Joshi, MD - Hollywood Private Hospital, Perth, Australia
Alternative lateral approach for hybrid ablation
- Konstantinos Zannis, MD - Institut Mutualiste Montsouris, Paris, France
1:00 pm - 2:00 pm
Networking Lunch
2:00 pm - 3:20 pm
Options in LAA management
- Nicolas Lellouche, MD - Hôpitaux Universitaires Henri Mondor, Créteil, France
- Massimo Mariani, MD - University Medical Center, Groeningen, Netherlands
Thrombogenic and arrhythmogenic properties of LAA
- Syed Ahsan, MD - St Bartholomew's Hospital, London, UK
Addressing the LAA in hybrid AF ablation procedures
- Aziz Momin, MD - St George's Hospital, London, UK
Epicardial vs endocardial options for LAA management during AF ablation
- Tom Wong, MD - Royal Brompton and Harefield Hospitals, London, UK
Latest results from aMaze trial
- Dhanunjaya R. Lakkireddy, MD - Kansas City Heart Rhythm Institute, Kansas City, MO, USA
Panel discussion
3:20 pm - 3:40 pm
Coffee Break
3:40 pm - 5:00 pm
Case base panel discussion: Building a standard of care
- Alexander Kaminski, MD - Klinikum Karlsburg, Karlsburg, Germany
- Faizel Osman, MD - University Hospital of Coventry and Warwickshire, Coventry, UK
Advancing Hybrid AF care in medical communities
- Jaswinder Gill, MD - Guy's and St Thomas' Hospitals, London, UK
Patient referral in Hybrid AF practice
- Stefan Bauer, MD - MediClin Heart Center, Lahr, Germany
Tailwinds and headwinds in starting an Hybrid AF program
- Matthew Ginks, MD – John Radcliffe Hospital, Oxford, UK
Lessons learnt as a proctor
- Eric Bergoënd, MD - Hôpitaux Universitaires Henri Mondor, Créteil, France
5:00 pm - 5:00 pm
Closing & departures